| P50 | author | Alexander Tropsha | Q4720252 |
| | Olexandr Isayev | Q42959384 |
| P2093 | author name string | Mariya Popova | |
| P2860 | cites work | Privileged scaffolds for library design and drug discovery | Q24604575 |
| | Long Short-Term Memory | Q24805158 |
| | The ChEMBL bioactivity database: an update | Q27144224 |
| | Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data | Q27301054 |
| | Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions | Q27702095 |
| | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 |
| | Mastering the game of Go with deep neural networks and tree search | Q28005460 |
| | Towards a Universal SMILES representation - A standard method to generate canonical SMILES based on the InChI | Q28133319 |
| | The use of Hasse diagrams as a potential approach for inverse QSAR. | Q52964695 |
| | Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors | Q61218037 |
| | Critical review of the role of HTS in drug discovery | Q83039041 |
| | QSAR modeling: where have you been? Where are you going to? | Q28222668 |
| | Computational chemistry-driven decision making in lead generation | Q28297397 |
| | Navigating chemical space for biology and medicine | Q28298611 |
| | PubChem BioAssay: 2017 update | Q28555205 |
| | Best Practices for QSAR Model Development, Validation, and Exploitation | Q28649930 |
| | Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research | Q28748220 |
| | Quantum-chemical insights from deep tensor neural networks | Q28817466 |
| | ZINC: a free tool to discover chemistry for biology | Q29615857 |
| | A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 |
| | The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology | Q30358084 |
| | Automated design of ligands to polypharmacological profiles. | Q30539786 |
| | Estimation of the size of drug-like chemical space based on GDB-17 data. | Q30662631 |
| | Rational Combinatorial Library Design. 2. Rational Design of Targeted Combinatorial Peptide Libraries Using Chemical Similarity Probe and the Inverse QSAR Approaches | Q32068681 |
| | Recent developments in de novo design and scaffold hopping | Q33329842 |
| | ANI-1: an extensible neural network potential with DFT accuracy at force field computational cost. | Q33631061 |
| | Computer-based de novo design of drug-like molecules | Q34438895 |
| | Active-learning strategies in computer-assisted drug discovery | Q35513071 |
| | Assessment of the consistency of medicinal chemists in reviewing sets of compounds. | Q35888315 |
| | Bayesian molecular design with a chemical language model. | Q36303825 |
| | Low Data Drug Discovery with One-Shot Learning | Q36362630 |
| | Process chemistry: The science, business, logic, and logistics | Q36534161 |
| | Artificial Intelligence in Precision Cardiovascular Medicine | Q38678805 |
| | The End of Radiology? Three Threats to the Future Practice of Radiology | Q38819101 |
| | Protein-Ligand Scoring with Convolutional Neural Networks. | Q38860867 |
| | Deep Learning in Drug Discovery. | Q38918718 |
| | How accurately can we predict the melting points of drug-like compounds? | Q39079351 |
| | Modelling Chemical Reasoning to Predict and Invent Reactions | Q39174978 |
| | Inverse QSPR/QSAR Analysis for Chemical Structure Generation (from y to x). | Q40052543 |
| | SIML: a fast SIMD algorithm for calculating LINGO chemical similarities on GPUs and CPUs | Q40398283 |
| | The properties of known drugs. 1. Molecular frameworks | Q40933327 |
| | Molecular de-novo design through deep reinforcement learning | Q42766915 |
| | SMILES as an alternative to the graph in QSAR modelling of bee toxicity | Q46911283 |
| | Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks | Q48024105 |
| | Artificial Intelligence. Amplify scientific discovery with artificial intelligence | Q51026998 |
| | A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules | Q51997288 |
| | Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. | Q52659131 |
| P4510 | describes a project that uses | Jupyter notebook file | Q70357595 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | deep learning | Q197536 |
| | deep reinforcement learning | Q65079156 |
| P304 | page(s) | eaap7885 | |
| P577 | publication date | 2018-07-01 | |
| P1433 | published in | Science Advances | Q19881044 |
| P1476 | title | Deep reinforcement learning for de novo drug design | |
| P478 | volume | 4 | |